Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a small patch to the page's metadata. The visible content and study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-21T13:15:02.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.3, signaling a recent update to the page. This change does not alter the study information displayed.
    Difference
    0.1%
    Check dated 2026-06-30T02:14:56.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', the recruitment status was updated to 'No longer looking for participants', and a site revision tag 'v3.6.0' indicates a recent update.
    Difference
    0.4%
    Check dated 2026-06-15T19:06:34.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.5.4 to v3.5.5, indicating a new iteration of the page's content or layout. No study details or results are changed.
    Difference
    0.1%
    Check dated 2026-06-08T16:22:09.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a small update to the page's versioning. There are no visible changes to the study data, eligibility criteria, or outcomes on the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:58:42.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    The page is updated to reflect a new ClinicalTrials.gov interface/release revision number (from v3.5.2 to v3.5.3). This represents a site maintenance/version change rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:38:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.